OXOLIFE
Oxolife is a biotech startup focused in R&D of reproductive efficiency and infertility treatments Oxolife (was founded in January 2013 by an entrepreneurial and multidisciplinary team formed biochemists and clinical Pharmacologist, with more than 10 year of expertise in R&D and pharmaceutical market.
OXOLIFE
Industry:
Biotechnology Health Care Medical
Founded:
2013-01-01
Address:
San Quírico Safaja, Catalonia, Spain
Country:
Spain
Website Url:
http://www.oxolife.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
100 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Investors List
BStartup
BStartup investment in Venture Round - OXOlife
Official Site Inspections
http://www.oxolife.com
- Host name: d425.dinaserver.com
- IP address: 82.98.144.53
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "OXOlife"
OXOlife - Crunchbase Company Profile & Funding
Oxolife is a biotechnology company in the clinical phase of development. Oxolife is a biotech startup focused in R&D of reproductive efficiency and infertility …See details»
About us - Oxolife
Oxolife’s innovation is a first-in-class oral drug for the treatment of infertile women, named OXO-001, that increases embryo implantation success and …See details»
OXOLIFE Company Profile - Office Locations, Competitors ... - Craft
OXOLIFE is a biotechnology company focused on female fertility. It develops OXO-001, a treatment to support female fertility success through acting on peri and post implantatory …See details»
Oxolife Company Profile 2024: Valuation, Funding
Oxolife has raised $11.2M. Who are Oxolife’s investors? Spain's Ministry of Science and Innovation, BStartup10 , Centro para el Desarrollo Tecnologico …See details»
Oxolife - Overview, News & Similar companies | ZoomInfo.com
Nov 13, 2023 Oxolife is a small-sized clinical-stage biotech company, founded in 2013 by Ignasi Canals and Agnès Arbat, focus and committed to female fertility improvement. Read More. …See details»
Oxolife | Sant Quirze del Vallès, Spain Startup - gust.com
Oxolife is a small sized clinical stage company developing a unique pharmacological product, OXO-001, for embryo endometrial implantation and ovulation recovery in polycystic ovarian …See details»
Oxolife Company Profile | Management and Employees List
Find contact information for Oxolife. Learn about their Drug Stores & Pharmacies, Retail market share, competitors, and Oxolife's email format.See details»
Oxolife - Company Profile - Tracxn
Oct 22, 2024 Oxolife ranks 11th among 42 active competitors. 17 of its competitors are funded while 8 have exited. Overall, Oxolife and its competitors have raised over $864M in funding …See details»
Oxolife - Products, Competitors, Financials, Employees, …
Oxolife primarily serves the healthcare industry, particularly the sector dealing with reproductive health and fertility. It was founded in 2013 and is based in Barcelona, Spain. Headquarters …See details»
OXOlife Company Profile: Overview and Full News Analysis
OXOlife is a biotechnology company based in Catalonia that focuses on enhancing reproductive efficiency. The company is dedicated to developing a drug that targets the endometrium to …See details»
Genesis Biomed | “We could hit a new milestone in the treatment …
Jun 9, 2024 Agnès Arbat and Ignasi Canals lead Oxolife, a startup that is developing OXO-001, a drug with the potential to treat female infertility as it increases the chances of embryo …See details»
Oxolife raises €5 million in a funding round and joins the …
The biotech Oxolife –focused on the development of a new treatment to improve the female fertility rate– has moved its headquarters to the Barcelona Science Park. The company, which …See details»
Genesis Biomed | Biotech company Oxolife raises 5 million euros …
Jun 15, 2024 Oxolife, created to develop a new treatment to improve female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready …See details»
News - Page 4 of 4 - Oxolife
Financial times: “oxolife is one of the 20 spanish healthcare companies to watch” June 2, 2020 The Barcelona based, women’s fertility startup has developed a molecule, OXO-001, that …See details»
A pill for infertility: Oxolife's non-hormonal oral drug raises …
Today, Oxolife is presenting highly promising new data at ESHRE from its proof-of-concept Phase 2 double-blinded, randomised controlled trial of OXO-001, in which it was tested against a …See details»
OXOART2, selected as one of the most exciting pieces of ... - Oxolife
Jul 8, 2024 The OXOLIFE exploratory subset study analysed 96 women aged up to 40 years old who underwent a single embryo transfer, 42 receiving placebo and 54 receiving a daily dose of …See details»
News - Page 3 of 4 - Oxolife
The video presentation of Oxolife as a new member of CataloniaBio Health Tech has already come to light. We are very … [Read more...] about We are Catalonia BioHT!See details»
News - Page 2 of 4 - Oxolife
Jun 2, 2021 After 9 months of recruiting women who are looking for pregnancy, we have finally passed our milestone with 403 patients … [Read more...] about At @OXOLIFE we are ...See details»
News - Oxolife
A pill for infertility: Oxolife’s non-hormonal oral drug raises embryo implantation rate, pregnancy rates and live birth rate in women undergoing IVF and ICSI, data being presented at ESHRE …See details»